Negative psychological and physiological consequences of neurodegenerative disorders
represent a high social and health cost. Among the neurodegenerative disorders …

Alzheimer's disease (AD) is one of the most common neurodegenerative disorders, with no
cure and preventive therapy. Misfolding and extracellular aggregation of Amyloid-β (Aβ) …

Depressive disorders can affect up to 350 million people worldwide, and in developed
countries, the percentage of patients with depressive disorders may be as high as 10 …

Human islet amyloid polypeptide (hIAPP) self-assembles into amyloid fibrils which deposit in
pancreatic islets of type 2 diabetes (T2D) patients. Here, we applied chemical kinetics to …

The potential to treat neurodegenerative diseases (NDs) of the major bioactive compound of
green tea, epigallocatechin-3-gallate (EGCG), is well documented. Numerous findings now …

Alzheimer's disease (AD) is an age-related chronic progressive neurodegenerative disease,
which is the main cause of dementia in the elderly. Much evidence shows that the onset and …

The aggregation of α‐synuclein (α‐Syn) is a critical pathological hallmark of Parkinson's
disease (PD). Prevention of α‐Syn aggregation has become a key strategy for treating PD …

The relevant social and economic costs associated with aging and neurodegenerative
diseases, particularly Alzheimer's disease (AD), entail considerable efforts to develop …

The misfolding and aggregation of the presynaptic protein α-synuclein (α-syn) is a
pathological hallmark of Parkinson's disease (PD). Targeting α-syn has emerged as a …

Amyloid fibrils share dominant β-sheet structures that form pathological deposits in human
organs causing various debilitating neurodegenerative diseases such as type II diabetes …